MGMT- The Forum

Please login or register.

Login with username, password and session length
Advanced search  

News:

Show Posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.

Messages - annacamille

Pages: [1]
Pages: [1]
D by surgery to remove the primary tumour. Poor responders (>10% viable tumour) will be randomised between map for 18 weeks and the mapie (methotrexate, doxorubicin, cisplatin, ifosfamide and etoposide) regime for 29 weeks. Good responders (<10% viable tumour) will be randomised between map for 18 weeks and mapinf, consisting of map for 18 weeks followed by maint. cialis S regimens given sequentially only once. A significant difference in median os was observed: 405 vs. 280 days for n (n=132) vs. C (n=65), respectively (p=0. 02). N was well tolerated, with no differences in adverse events between arms. Conclusions: no statistical differences in pfs or os for n vs. Bsc (usually with continuation of tki therapy) were demonstrated in the itt population. The mixed pt p.